These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26806748)

  • 1. [Restriction landmark genomic scanning for screening aberrant CpG methylations in prostate cancer].
    Li D; Xu Z; Liu J; Pu X; Luo Y; Zheng X
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):103-8. PubMed ID: 26806748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma.
    Chuang CK; Chu DC; Tzou RD; Liou SI; Chia JH; Sun CF
    Cancer Detect Prev; 2007; 31(1):59-63. PubMed ID: 17291695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of CpG islands in primary and metastatic human prostate cancer.
    Yegnasubramanian S; Kowalski J; Gonzalgo ML; Zahurak M; Piantadosi S; Walsh PC; Bova GS; De Marzo AM; Isaacs WB; Nelson WG
    Cancer Res; 2004 Mar; 64(6):1975-86. PubMed ID: 15026333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH; Lee S; Lee HJ; Hwang KS
    J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.
    Ellinger J; Bastian PJ; Jurgan T; Biermann K; Kahl P; Heukamp LC; Wernert N; Müller SC; von Ruecker A
    Urology; 2008 Jan; 71(1):161-7. PubMed ID: 18242387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
    Nakayama M; Gonzalgo ML; Yegnasubramanian S; Lin X; De Marzo AM; Nelson WG
    J Cell Biochem; 2004 Feb; 91(3):540-52. PubMed ID: 14755684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma.
    Chu DC; Chuang CK; Fu JB; Huang HS; Tseng CP; Sun CF
    J Urol; 2002 Apr; 167(4):1854-8. PubMed ID: 11912447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin B receptor gene hypermethylation in prostate adenocarcinoma.
    Jerónimo C; Henrique R; Campos PF; Oliveira J; Caballero OL; Lopes C; Sidransky D
    J Clin Pathol; 2003 Jan; 56(1):52-5. PubMed ID: 12499435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of genes for diagnosis and risk stratification of prostate cancer.
    Vanaja DK; Ehrich M; Van den Boom D; Cheville JC; Karnes RJ; Tindall DJ; Cantor CR; Young CY
    Cancer Invest; 2009 Jun; 27(5):549-60. PubMed ID: 19229700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer.
    Millar DS; Ow KK; Paul CL; Russell PJ; Molloy PL; Clark SJ
    Oncogene; 1999 Feb; 18(6):1313-24. PubMed ID: 10022813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between the expression of DNMT1, and GSTP1 and APC, and the methylation status of GSTP1 and APC in association with their clinical significance in prostate cancer.
    Zhang W; Jiao H; Zhang X; Zhao R; Wang F; He W; Zong H; Fan Q; Wang L
    Mol Med Rep; 2015 Jul; 12(1):141-6. PubMed ID: 25738352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
    Enokida H; Shiina H; Igawa M; Ogishima T; Kawakami T; Bassett WW; Anast JW; Li LC; Urakami S; Terashima M; Verma M; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Cancer Res; 2004 Sep; 64(17):5956-62. PubMed ID: 15342374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing.
    Vasiljević N; Wu K; Brentnall AR; Kim DC; Thorat MA; Kudahetti SC; Mao X; Xue L; Yu Y; Shaw GL; Beltran L; Lu YJ; Berney DM; Cuzick J; Lorincz AT
    Dis Markers; 2011; 30(4):151-61. PubMed ID: 21694441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
    Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTPIP51 mRNA and protein expression in tissue microarrays and promoter methylation of benign prostate hyperplasia and prostate carcinoma.
    Koch P; Petri M; Paradowska A; Stenzinger A; Sturm K; Steger K; Wimmer M
    Prostate; 2009 Dec; 69(16):1751-62. PubMed ID: 19691131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
    Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
    Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.
    Chung W; Kwabi-Addo B; Ittmann M; Jelinek J; Shen L; Yu Y; Issa JP
    PLoS One; 2008 Apr; 3(4):e2079. PubMed ID: 18446232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restriction landmark genomic scanning: analysis of CpG islands in genomes by 2D gel electrophoresis.
    Costello JF; Hong C; Plass C; Smiraglia DJ
    Methods Mol Biol; 2009; 507():131-48. PubMed ID: 18987812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer.
    Sørensen KD; Borre M; Ørntoft TF; Dyrskjøt L; Tørring N
    Int J Cancer; 2008 Feb; 122(3):509-19. PubMed ID: 17943724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.